IDEXX Laboratories Inc
IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 17/3038% above fair value
$698.47+8.23 (+1.19%)
Close on Nov 18, 2026Market cap $55.03BP/E 49.1Yield –
IDEXX Laboratories U.S. Companion Animal Veterinary Practice Trends by Quarter
U.S. Companion Animal Veterinary Practice Trends (IDEXX Practice Intelligence) (%)
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Companion Animal Veterinary Practice Trends (IDEXX Practice Intelligence) (%) | Year on year | Source |
|---|
Breakdown
What makes up U.S. Companion Animal Veterinary Practice Trends
- U.S. Same-Store Practice Total Revenue YoY Growth2.4% · Q3 2026
- U.S. Same-Store Practice Total Visits YoY Growth-3.2% · Q3 2026
- U.S. Same-Store Clinical Visits YoY Growth-1.8% · Q3 2026
- U.S. Companion Animal Diagnostic Revenue per Practice YoY Growth5.5% · Q3 2026
- IDEXX U.S. CAG Diagnostics Recurring Growth Premium vs. U.S. Clinical Visits1,100 · Q3 2026
Cite this data
StockData. (2026). IDEXX Laboratories U.S. Companion Animal Veterinary Practice Trends (%), quarterly [Data set]. Compiled from IDEXX Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/idxx/kpis/us-practice-intelligence-header
See every metric in the IDEXX Laboratories KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?